EGFR‐mutated stage IV non‐small cell lung cancer: What is the role of radiotherapy combined with TKI?

Lung cancer is the leading cause of cancer‐related death globally and poses a considerable threat to public health. Asia has the highest prevalence of epidermal growth factor receptor (EGFR) mutations in patients with non‐small cell lung cancer (NSCLC). Despite the reasonable response and prolonged...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bailong, Liu, Hui, Ma, Yunfei, Ding, Qiuhui, Zhang, Min, Liu, Xinliang, Liu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446557/
https://www.ncbi.nlm.nih.gov/pubmed/34374490
http://dx.doi.org/10.1002/cam4.4192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446557/
https://www.ncbi.nlm.nih.gov/pubmed/34374490
http://dx.doi.org/10.1002/cam4.4192

Ejemplares similares